Fig. 5
From: Celastrol-based nanomedicine promotes corneal allograft survival
CPNM prolonged the corneal allograft survival. A Clinical manifestations (magnification, ×250) of the anterior segment on postoperative 8 days and 14 days. Representative photographs of the corneal allografts which were treated with or without CPNM at post-operative 8 days and 14 days. B Survival curves of rat corneal grafts for two groups. The average survival time of corneal graft in the control group was about 7.3 ± 0.6 days, while that in the CPNM group was 29.1 days ± 2.4 days. C Corneal transparency, edema, corneal neovascularization and total scores of each group were compared. Within about 27 days after surgery, scores in the CPNM group were significantly lower than those in the control group, with statistically significant differences